Prothena (PRTA) Earnings Date & Reports

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PRTA is expected to report earnings to rise 5.56% to -37 cents per share on November 05

Q3'26

Est.

$-0.38

Q2'26

Missed

by $0.68

Q1'26

Beat

by $0.95

Q4'25

Beat

by $0.19

Q3'25

Beat

by $0.04

The last earnings report on August 06 showed earnings per share of -36 cents, missing the estimate of 32 cents. With 243.07K shares outstanding, the current market capitalization sits at 431.23M.

View a ticker or compare two or three

Ask AI

Compare

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

Realized ReturnView

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

PRTA

Setup

Daily Signal:

Description

Gain/Loss: